Role of nitric oxide and phosphodiesterase isoenzyme II for reduction of endothelial hyperpermeability

American Journal of Physiology - Cell Physiology

Volumn 270, Issue 3 39-3, 1996, Pages

  Suttorp, Norbert ^a   Hippenstiel, Stefan ^b   Fuhrmann, Martin ^b   Krüll, Matthias ^b   Podzuweit, Thomas ^b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b NONE

Author keywords

adult respiratory distress syndrome; hydrogen peroxide; nitric oxide donors; vascular leakage

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHODIESTERASE;

ANIMAL CELL; ARTICLE; CELL MEMBRANE PERMEABILITY; CONDUCTANCE; ENDOTHELIUM CELL; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; SWINE;

EID: 0029874897     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.1996.270.3.c778     Document Type: Article

References (34)

1. Ahlner, J., R. G. G. Andersson, K. Torfgard, and K. L. Axelsson. Organic nitrate esters: clinical use and mechanisms of actions. Pharmacol. Rev. 43: 351-423, 1991.
2. Beavo, J. A., and D. H. Reifsnyder. Primary sequence of cyclic micleotide phosphodiesterase isoenzymes and the design of selective inhibitors. Trends Pharmacol. Sci. 11. 150-155, 1990.
3. Bhakdi, S., S. Greulich, M. Muhly, B. Eberspächer, H. Becker, A. Thiele, and F. Hugo. Potent leukocidal action of E. coli hemolysin mediated by permeabilization of target cell membranes. J. Exp. Med. 169: 737-754, 1989.
4. Dunn, O. J., and V. A. Clark. Applied Statistics: Analysis of Variance and Regression. New York: Wiley, 1974.
5. Henderson, J. F., L. Brox, G. Zombor, D. Hunting, and C. A. Lomax. Specificity of adenosine deaminase inhibitors. Biochem. Pharmacol. 26: 1967-1972, 1977.
6. Hyslop, P.A., D. B. Hinshaw, W. A. Halsey, I. U. Schraufstätter, R. D. Sauerheber, R. G. Spragg, J. H. Jackson, and C. G. Cochrane. Mechanisms of oxidant-mediated cell injury. J. Biol. Chem. 263: 1665-1675, 1988.
7. Ignarro, L. J. Nitric oxide mediated vasorelaxation. Thromb. Haemostasia 70: 148-151, 1993.
8. Kubes, P. Nitric oxide-induced microvascular permeability alterations: a regulatory role for cGMP. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H1909-H1915, 1993
9. Kurose, I., P. Kubes, R. Wolf, D. C. Anderson, J. Paulson, M. Miyasaka, and D. N. Granger. Inhibition of nitric oxide production: mechanisms of vascular albumin leakage. Circ. Res. 73: 164-171, 1993.
10. Lang, D., and M. J. Lewis. Inhibition of inositol 1,4,5-trisphosphate formation by cyclic GMP in cultured aortic endothelial cells of the pig. J. Pharmacol. 102: 277-281, 1991.
11. Lincoln, T. M., and T. L. Cornwell. Intracellular cyclic GMP receptor proteins. FASEB J. 7: 328-338, 1993.
12. Lofton, E. C., W. H. Newman, and M. G. Currie. Atrial natriuretic peptide regulation of endothelial permeability is mediated by cGMP. Biochem. Biophys. Res. Commun. 172: 793-799, 1990.
13. Lugnier, C., and V. B. Schini. Characterization of cyclic nucleotide phosphodiesterases from cultured bovine aortic endothelial cells. Biochem. Pharmacol. 39: 75-84, 1990.
14. MacMillan-Crow, L. A., J. E. Murphy-Ullrich, and T. M. Lincoln. Identification and possible localization of cGMP-dependent protein kinase in bovine aortic endothehal cells. Biochem. Biophys. Res. Commun. 201: 531-537, 1994.
15. Malik, A. B., W. M. Selig, and K. E. Burhop. Cellular and humoral mediators of pulmonary edema. Lung 163: 193-219, 1985
16. 4-induced increases in microvascular transport. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H409-H414, 1993
17. Meyer, D. J., and V. H. Huxley. Capillary hydraulic conductivity is elevated by cGMP-dependent vasodilators. Circ. Res. 70: 382-391, 1992.
18. Nathan, C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6: 3051-3064, 1992.
19. Oliver, J. A. Endothelium-derived relaxing factor contributes to the regulation of endothelial permeability. J. Cell. Physiol. 151: 506-511, 1992
20. Podzuweit, T., A. Müller, and P. Nennstiel. Selective inhibition of the cGMP-stimulated cyclic nucleotide phosphodiesterase from pig and human myocardium (Abstract). J. Mol. Cell Cardiol 24, Suppl.: 102, 1992.
21. Podzuweit, T., A. Müller, and L. H. Opie. Anti-arrythmic effects of selective inhibition of myocardial phosphodiesterase II. Lancet 341: 760, 1993.
22. Ruskoaho, H. Atrial natriuretic peptide: synthesis, release and metabolism. Pharmacol. Rev. 44: 479-592, 1992.
23. Schnittler, H., A. Wilke, T. Gress, N. Suttorp, and D. Drenckhahn. Role of endothelial actin and myosin in the control of paracellular permeability. J. Physiol. Lond. 431: 379-401, 1990.
24. Shasby, D. M., M. Yorek, and S. S. Shasby. Exogenous oxidants initiate hydrolysis of endothelial cell inositol phospholipids. Blood 72: 491-499, 1988.
25. Souness, J. E., B. K. Diocee, W. Martin, and S. A. Moodie. Pig aortic endothelial cell nucleotide phosphodiesterases. Biochem. J. 266: 127-132, 1990.
26. Suttorp, N., M. Fuhrmann, S. Tannert-Otto, and S. Bhakdi. Pore-forming bacterial toxins potently induce release of nitric oxide in porcine endothelial cells. J. Exp. Med. 178: 337-341, 1993.
27. Suttorp, N., T. Hessz, W. Seeger, A. Wilke, R. Koob, F. Lutz, and D. Drenckhahn. Bacterial exotoxins and endothelial permeability for water and albumin. Am. J. Physiol. 255 (Cell Physiol. 24): C369-C376, 1988.
28. 2 toxin increases endothelial permeability in vitro. J. Clin. Invest. 87: 1575-1584, 1991.
29. Suttorp, N., W. Toepfer, and L. Roka. Antioxidant defense systems in endothelial cells: glutathione redox cycle versus catalase. Am. J. Physiol. 251 (Cell Physiol. 20): C671-C680, 1986.
30. Suttorp, N., U. Weber, T. Welsch, and C. Schudt. Role of phosphodiesterases in the regulation of endothelial permeability in vitro. J. Clin. Invest. 91: 1421-1428, 1993.
31. Torphy, T. J., and B. J. Undem. Phosphodiesterase inhibitors: new opportunities for the treatment of asthma. Thorax 46: 512-523; 1991.
32. Walter, U. Physiological role of cGMP and cGMP-dependent protein kinase in the cardiovascular system. Rev. Physiol. Biochem. Pharmacol. 113: 41-88, 1989.
33. Wong, S. K. F., and D. L. Garbers. Receptor guanylyl cyclases. J. Clin. Invest. 90: 299-305, 1992.
34. Yuan, Y., H. J. Granger, D. C. Zawieja; D. V. DeFily, and W. M. Chilian. Histamine increases venular permeability via a phospholipase C-NO synthase-guanylate cyclase cascade. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H1734-H1739, 1993.